knowledge -WSS

knowledge

author：hotspot 2025-09-28 01:39:45 - browse：129

Peter Marks. -- health coverage from STAT — Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration. Susan Walsh-Pool/Getty Images

Peter Marks wants drug developers to ask more stupid questions.

It’s part of the top Food and Drug Administration official’s plan to reinvigorate gene therapy, a field that has struggled despite significant technological advances. Some companies are shelving programs or going out of business, even when they have promising data.

The problems are numerous: The diseases are often exceptionally rare, limiting the potential market. Manufacturing at commercial quality is complex and expensive. Proving a drug works can be difficult, because there may be too few patients to run a traditional randomized study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Why do women spend more than men on medical expenses?

WSS

Gene therapy has helped boys walk. Can scientists keep it that way?

Donald Trump's relentless attacks on special counsel Jack Smith

Death of patient in Alzheimer’s trial raises question of possible risks

Weight bias in eating disorder treatment complicated by new weight loss drugs

Researchers use wearables data and AI to predict preterm birth risk

Covid vaccines: Private market messier than government rollout

focus

knowledge

knowledge

Apple is now the first public company to be valued at $3 trillion

WATCH: Why do fingernails fall off when they're damaged?

23andMe had bad news about my health. I wish a person had delivered it

Covid vaccines: Private market messier than government rollout

Duchenne breakthrough therapy leaves behind pioneering families

The science behind Janet Jackson's pregnancy at 49

Peter Hotez and the public health issue of online harassment

Donald Trump's relentless attacks on special counsel Jack Smith

How one medical school became remarkably diverse

Senator probes 340B programs at Cleveland Clinic, Bon Secours

explore

New guidelines on severe brain injury complicate already difficult decisions

FDA seeks to regulate lab

FDA seeks to regulate lab

3 hurdles to bringing medical devices to the U.S. market

Why drug prescriptions should include diagnoses

FDA advisers vote against ALS treatment from BrainStorm

hotspot

hotspot

focus

Wikipedia